{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:12:29Z","timestamp":1771607549018,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00417-022-05840-1","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T02:02:54Z","timestamp":1664848974000},"page":"1029-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Short-term results of a pulsed therapy with hydrocortisone eye drops to treat moderate to severe dry eye in primary Sj\u00f6gren syndrome patients"],"prefix":"10.1007","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1614-0107","authenticated-orcid":false,"given":"Martina","family":"Menchini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Sartini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Figus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Gabbriellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"5840_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2011.06.007","volume":"141","author":"R Jonsson","year":"2011","unstructured":"Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S (2011) The complexity of Sjogren\u2019s syndrome: novel aspects on pathogenesis. Immunol Lett 141:1\u20139. https:\/\/doi.org\/10.1016\/j.imlet.2011.06.007","journal-title":"Immunol Lett"},{"key":"5840_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/ICO.0000000000001865","volume":"38","author":"EK Akpek","year":"2019","unstructured":"Akpek EK, Bunya VY, Saldanha IJ (2019) Sjogren\u2019s syndrome: more than just dry eye. Cornea 38:658\u2013661. https:\/\/doi.org\/10.1097\/ICO.0000000000001865","journal-title":"Cornea"},{"key":"5840_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1477-7525-7-46","volume":"7","author":"B Segal","year":"2009","unstructured":"Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, Ogale S, McLean L (2009) Primary Sjogren\u2019s syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 7:46. https:\/\/doi.org\/10.1186\/1477-7525-7-46","journal-title":"Health Qual Life Outcomes"},{"key":"5840_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","volume":"13","author":"GN Foulks","year":"2015","unstructured":"Foulks GN, Forstot SL, Donshik PC, Forstot JZ, Goldstein MH, Lemp MA, Nelson JD, Nichols KK, Pflugfelder SC, Tanzer JM, Asbell P, Hammitt K, Jacobs DS (2015) Clinical guidelines for management of dry eye associated with Sjogren disease. Ocul Surf 13:118\u2013132. https:\/\/doi.org\/10.1016\/j.jtos.2014.12.001","journal-title":"Ocul Surf"},{"key":"5840_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/s0008-4182(04)80071-1","volume":"39","author":"FA Adatia","year":"2004","unstructured":"Adatia FA, Michaeli-Cohen A, Naor J, Caffery B, Bookman A, Slomovic A (2004) Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjogren\u2019s syndrome. Can J Ophthalmol 39:767\u2013771. https:\/\/doi.org\/10.1016\/s0008-4182(04)80071-1","journal-title":"Can J Ophthalmol"},{"key":"5840_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F (2017) TFOS DEWS II definition and classification report. Ocul Surf 15:276\u2013283. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008","journal-title":"Ocul Surf"},{"key":"5840_CR7","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1167\/iovs.08-2689","volume":"50","author":"H Liu","year":"2009","unstructured":"Liu H, Begley C, Chen M, Bradley A, Bonanno J, McNamara NA, Nelson JD, Simpson T (2009) A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci 50:3671\u20133679. https:\/\/doi.org\/10.1167\/iovs.08-2689","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5840_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, Dong PN, Geerling G, Hida RY, Liu Y, Seo KY, Tauber J, Wakamatsu TH, Xu J, Wolffsohn JS, Craig JP (2017) TFOS DEWS II management and therapy report. Ocul Surf 15:575\u2013628. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.006","journal-title":"Ocul Surf"},{"key":"5840_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/s0161-6420(99)00176-1","volume":"107","author":"K Sall","year":"2000","unstructured":"Sall K, Stevenson OD, Mundorf TK, Reis BL (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmol 107:631\u2013639. https:\/\/doi.org\/10.1016\/s0161-6420(99)00176-1","journal-title":"Ophthalmol"},{"key":"5840_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000328630","volume":"47","author":"MR Razeghinejad","year":"2012","unstructured":"Razeghinejad MR, Katz LJ (2012) Steroid-induced iatrogenic glaucoma. Ophthalmic Res 47:66\u201380. https:\/\/doi.org\/10.1159\/000328630","journal-title":"Ophthalmic Res"},{"key":"5840_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12325-019-01137-8","volume":"37","author":"M Kallab","year":"2020","unstructured":"Kallab M, Szegedi S, Hommer N, Stegmann H, Kaya S, Werkmeister RM, Schmidl D, Schmetterer L, Garhofer G (2020) Topical low dose preservative-free hydrocortisone reduces signs and symptoms in patients with chronic dry eye: a randomized clinical trial. Adv Ther 37:329\u2013341. https:\/\/doi.org\/10.1007\/s12325-019-01137-8","journal-title":"Adv Ther"},{"key":"5840_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/00055735-200012000-00016","volume":"11","author":"MC Carnahan","year":"2000","unstructured":"Carnahan MC, Goldstein DA (2000) Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 11:478\u2013483. https:\/\/doi.org\/10.1097\/00055735-200012000-00016","journal-title":"Curr Opin Ophthalmol"},{"key":"5840_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"CN McGhee","year":"2002","unstructured":"McGhee CN, Dean S, Danesh-Meyer H (2002) Locally administered ocular corticosteroids: benefits and risks. Drug Saf 25:33\u201355. https:\/\/doi.org\/10.2165\/00002018-200225010-00004","journal-title":"Drug Saf"},{"key":"5840_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12325-016-0315-8","volume":"33","author":"JD Sheppard","year":"2016","unstructured":"Sheppard JD, Comstock TL, Cavet ME (2016) Impact of the topical ophthalmic corticosteroid loteprednol etabonate on intraocular pressure. Adv Ther 33:532\u2013552. https:\/\/doi.org\/10.1007\/s12325-016-0315-8","journal-title":"Adv Ther"},{"key":"5840_CR15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558. https:\/\/doi.org\/10.1136\/ard.61.6.554","journal-title":"Ann Rheum Dis"},{"key":"5840_CR16","doi-asserted-by":"publisher","unstructured":"(1991) Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 98: 741\u2013756.\u00a0https:\/\/doi.org\/10.1016\/s0161-6420(13)38009-9","DOI":"10.1016\/s0161-6420(13)38009-9"},{"key":"5840_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, Sullivan BD, Tomlinson A, Tong L, Villani E, Yoon KC, Jones L, Craig JP (2017) TFOS DEWS II diagnostic methodology report. Ocul Surf 15:539\u2013574. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.001","journal-title":"Ocul Surf"},{"key":"5840_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22:640\u2013650. https:\/\/doi.org\/10.1097\/00003226-200310000-00008","journal-title":"Cornea"},{"key":"5840_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/s0275-5408(97)00066-5","volume":"18","author":"N Efron","year":"1998","unstructured":"Efron N (1998) Grading scales for contact lens complications. Ophthalmic Physiol Opt 18:182\u2013186. https:\/\/doi.org\/10.1016\/s0275-5408(97)00066-5","journal-title":"Ophthalmic Physiol Opt"},{"key":"5840_CR20","doi-asserted-by":"publisher","first-page":"E760","DOI":"10.1097\/OPX.0b013e3182512ac1","volume":"89","author":"H Pult","year":"2012","unstructured":"Pult H, Nichols JJ (2012) A review of meibography. Optom Vis Sci 89:E760-769. https:\/\/doi.org\/10.1097\/OPX.0b013e3182512ac1","journal-title":"Optom Vis Sci"},{"key":"5840_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 118:615\u2013621. https:\/\/doi.org\/10.1001\/archopht.118.5.615","journal-title":"Arch Ophthalmol"},{"key":"5840_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/s0002-9394(03)00326-x","volume":"136","author":"AM Avunduk","year":"2003","unstructured":"Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE (2003) The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 136:593\u2013602. https:\/\/doi.org\/10.1016\/s0002-9394(03)00326-x","journal-title":"Am J Ophthalmol"},{"key":"5840_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","volume":"138","author":"SC Pflugfelder","year":"2004","unstructured":"Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R (2004) A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 138:444\u2013457. https:\/\/doi.org\/10.1016\/j.ajo.2004.04.052","journal-title":"Am J Ophthalmol"},{"key":"5840_CR24","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1097\/MD.0000000000000551","volume":"94","author":"T Lin","year":"2015","unstructured":"Lin T, Gong L (2015) Topical fluorometholone treatment for ocular dryness in patients with Sjogren syndrome: a randomized clinical trial in China. Medicine (Baltimore) 94:e551. https:\/\/doi.org\/10.1097\/MD.0000000000000551","journal-title":"Medicine (Baltimore)"},{"key":"5840_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5301\/ejo.5000229","volume":"23","author":"P Aragona","year":"2013","unstructured":"Aragona P, Spinella R, Rania L, Postorino E, Sommario MS, Roszkowska AM, Puzzolo D (2013) Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sjogren syndrome. Eur J Ophthalmol 23:368\u2013376. https:\/\/doi.org\/10.5301\/ejo.5000229","journal-title":"Eur J Ophthalmol"},{"key":"5840_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","volume":"106","author":"P Marsh","year":"1999","unstructured":"Marsh P, Pflugfelder SC (1999) Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmol 106:811\u2013816. https:\/\/doi.org\/10.1016\/S0161-6420(99)90171-9","journal-title":"Ophthalmol"},{"key":"5840_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","volume":"137","author":"SC Pflugfelder","year":"2004","unstructured":"Pflugfelder SC (2004) Antiinflammatory therapy for dry eye. Am J Ophthalmol 137:337\u2013342. https:\/\/doi.org\/10.1016\/j.ajo.2003.10.036","journal-title":"Am J Ophthalmol"},{"key":"5840_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/jop.2016.0147","volume":"33","author":"M Rolando","year":"2017","unstructured":"Rolando M, Vagge A (2017) Safety and efficacy of cortisol phosphate in hyaluronic acid vehicle in the treatment of dry eye in Sjogren syndrome. J Ocul Pharmacol Ther 33:383\u2013390. https:\/\/doi.org\/10.1089\/jop.2016.0147","journal-title":"J Ocul Pharmacol Ther"},{"key":"5840_CR29","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/ICO.0b013e31812f6782","volume":"26","author":"JY Hyon","year":"2007","unstructured":"Hyon JY, Lee YJ, Yun PY (2007) Management of ocular surface inflammation in Sjogren syndrome. Cornea 26:S13-15. https:\/\/doi.org\/10.1097\/ICO.0b013e31812f6782","journal-title":"Cornea"},{"key":"5840_CR30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA (2017) TFOS DEWS II pathophysiology report. Ocul Surf 15:438\u2013510. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.011","journal-title":"Ocul Surf"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05840-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05840-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05840-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T07:05:23Z","timestamp":1679987123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05840-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["5840"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05840-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the (CEAVNO, Comitato Etico Area Vasta Nordovest, register number: ID19847) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}